Description

Bifendate Tablets, manufactured by Jiangsu Pengyao Pharmaceutical Co., Ltd., contain 25mg of the active ingredient bifendate per tablet. These tablets are widely used in scientific studies related to liver protection, hepatic detoxification, and antioxidant pathways. With a strong safety profile in preclinical models, bifendate is often studied for its membrane-stabilizing and anti-inflammatory properties.

This product is approved under NMPA Registration No. H32026034, and packaged as 12 tablets per box.

Notice: This product is intended only for laboratory and research use, not for therapeutic or diagnostic applications in humans or animals.

Product Specifications

Mechanism of Action

Bifendate is a synthetic derivative of schisandrin C, acting as a hepatoprotective agent. It is known to stabilize hepatic cell membranes, inhibit lipid peroxidation, and enhance detoxification enzymes, making it valuable in research on chemical-induced liver injury and oxidative stress.

Research Applications

• Hepatic detoxification studies

• Liver injury and hepatocyte protection models

• Free radical and oxidative damage research

• Preclinical pharmacological testing

• Anti-inflammatory studies in liver models

Core Keywords

• Bifendate Tablets 25mg

• CAS 42562-95-4

• Hepatoprotective compound

• Liver detox research

• Bifendate Jiangsu Pengyao

• Buy bifendate for lab use

• Liver injury model drug

• Experimental hepatoprotective agent

Disclaimer

This product is strictly not intended for medical or veterinary use. It is to be handled by qualified researchers in compliance with local regulations. Use is limited to laboratory or industrial research applications only.